Kiniksa Pharmaceuticals International, plc (KNSA) stock
KNSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 14/30469% above fair value
$95.05−0.06 (-0.06%)
Close on Nov 18, 2026Market cap $14.94BP/E 73.1Yield –
Kiniksa Pharmaceuticals International market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Kiniksa Pharmaceuticals International's market cap was $7.84B on Nov 11, 2026, against $3.26B a year earlier. Over the last 5 years it ranged from $526.95M to $7.84B, with a median of $1.43B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $7.84B | +148.2% |
| 2025 | Dec 31, 2025 | $3.16B | +119.5% |
| 2024 | Dec 31, 2024 | $1.44B | +16.3% |
| 2023 | Dec 29, 2023 | $1.24B | +19.0% |
| 2022 | Dec 30, 2022 | $1.04B | +29.4% |
| 2021 | Dec 31, 2021 | $804.58M | -22.2% |
| 2020 | Dec 31, 2020 | $1.03B | +78.3% |
| 2019 | Dec 31, 2019 | $579.90M | +16.0% |
| 2018 | Dec 31, 2018 | $500.03M | – |
See a number that looks wrong?